SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039841
Filing Date
2023-11-08
Accepted
2023-11-08 09:24:05
Documents
20
Period of Report
2023-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50453
2 ex1-1.htm EX-1.1 116474
3 ex4-1.htm EX-4.1 117622
4 ex5-1.htm EX-5.1 16208
5 ex10-1.htm EX-10.1 237383
6 ex99-1.htm EX-99.1 13133
7 ex5-1_002.jpg GRAPHIC 2274
8 ex99-1_001.jpg GRAPHIC 3052
9 ex99-1_002.jpg GRAPHIC 3052
  Complete submission text file 0001493152-23-039841.txt   844956

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE orgs-20231108.xsd EX-101.SCH 3018
11 XBRL LABEL FILE orgs-20231108_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE orgs-20231108_pre.xml EX-101.PRE 22361
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3183
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 231386303
SIC: 2834 Pharmaceutical Preparations